Profile data is unavailable for this security.
About the company
MediciNova, Inc. is a biopharmaceutical company that is developing therapeutics with a primary focus on neurology, respiratory and liver diseases. The Company's development activities are focused on MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction (methamphetamine dependence, opioid dependence and alcohol dependence), prevention of acute respiratory distress syndrome, and Long COVID, and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease and hypertriglyceridemia. Its MN-166 (ibudilast) is a first-in-class, oral, anti-inflammatory and neuroprotective agent. The FDA has granted Fast Track designations to MN-166 (ibudilast) for three separate indications: progressive MS, ALS, and methamphetamine dependence.
- Revenue in USD (TTM)257.92k
- Net income in USD-12.01m
- Incorporated2000
- Employees13.00
- LocationMediciNova Inc4275 Executive Square, Suite 300LA JOLLA 92037United StatesUSA
- Phone+1 (858) 373-1500
- Fax+1 (858) 404-0048
- Websitehttps://medicinova.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMS Co Ltd | 0.00 | -670.20m | 6.50bn | 18.00 | -- | 2.17 | -- | -- | -15.72 | -15.72 | 0.00 | 65.78 | 0.00 | -- | -- | 0.00 | -21.59 | -- | -22.41 | -- | -- | -- | -- | -- | 23.99 | -- | 0.00 | -- | -- | -- | 31.20 | -- | -- | -- |
| Cyfuse Biomedical KK | -100.00bn | -100.00bn | 6.75bn | 21.00 | -- | 2.27 | -- | -- | -- | -- | -- | 298.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.80 | -- | 0.3038 | -- | -10.91 | -- | -48.03 | -- | -- | -- |
| Noile-Immune Biotech Inc | 7.14m | -782.47m | 6.76bn | 25.00 | -- | 1.64 | -- | 945.69 | -18.07 | -18.07 | 0.165 | 95.16 | 0.0016 | 0.00 | 0.0668 | 285,720.00 | -17.08 | -- | -17.32 | -- | 30.00 | -- | -10,954.38 | -- | 60.62 | -- | 0.00 | -- | -97.61 | -- | 14.65 | -- | -- | -- |
| PRISM BioLab Co Ltd | 677.33m | -833.70m | 7.17bn | 35.00 | -- | 2.64 | -- | 10.58 | -22.84 | -22.84 | 18.54 | 73.59 | 0.1779 | -- | 12.58 | 19,352,290.00 | -21.90 | -- | -26.79 | -- | 39.83 | -- | -123.09 | -- | -- | -- | 0.00 | -- | 121.62 | -- | 20.56 | -- | -- | -- |
| Tsubota Laboratory Inc | 973.21m | -172.89m | 7.25bn | 17.00 | -- | 5.61 | -- | 7.45 | -6.79 | -6.79 | 37.61 | 50.08 | 0.4733 | 0.6726 | 4.00 | 57,247,590.00 | -8.41 | 0.1041 | -12.17 | 0.1517 | 80.27 | 71.43 | -17.76 | 0.2216 | 2.89 | -- | 0.0586 | 0.00 | 101.49 | 25.17 | 132.08 | 132.70 | 26.42 | -- |
| OncoTherapy Science, Inc. | 956.86m | -824.72m | 7.53bn | 47.00 | -- | 4.11 | -- | 7.87 | -2.90 | -2.90 | 3.38 | 4.86 | 0.5494 | 6.24 | 21.50 | 20,358,640.00 | -47.35 | -63.66 | -58.01 | -77.43 | 8.44 | -0.3852 | -86.19 | -184.75 | 8.21 | -567.86 | 0.0139 | -- | 22.93 | 18.86 | 36.71 | -- | -70.80 | -- |
| Linical Co Ltd | 9.87bn | -1.19bn | 7.84bn | 598.00 | -- | 1.18 | -- | 0.7946 | -52.52 | -52.52 | 437.00 | 267.76 | 0.6226 | -- | 3.69 | 16,505,640.00 | -7.48 | 2.59 | -13.50 | 4.19 | 21.61 | 29.24 | -12.02 | 3.74 | -- | -- | 0.2584 | 77.26 | -15.20 | -0.9283 | -259.37 | -- | -42.01 | 4.24 |
| Medinet Co Ltd | 810.29m | -1.36bn | 7.97bn | 107.00 | -- | 2.10 | -- | 9.84 | -5.15 | -5.15 | 3.06 | 14.27 | 0.1628 | 14.02 | 3.35 | 7,572,813.00 | -27.37 | -22.42 | -28.82 | -23.64 | 13.54 | 17.68 | -168.10 | -173.59 | 15.28 | -- | 0.00 | -- | 5.44 | 0.6867 | -6.67 | -- | 10.06 | -- |
| Chiome Bioscience Inc | 593.29m | -982.78m | 8.20bn | 47.00 | -- | 7.20 | -- | 13.81 | -14.48 | -14.48 | 8.74 | 16.39 | 0.2828 | 4.97 | 9.64 | -- | -46.84 | -52.22 | -59.06 | -64.41 | 59.93 | 57.59 | -165.65 | -174.88 | 3.99 | -1,177.61 | 0.1891 | -- | -24.02 | 4.29 | 3.72 | -- | -- | -- |
| Chordia Therapeutics Inc | 0.00 | -1.46bn | 8.68bn | 20.00 | -- | 3.64 | -- | -- | -21.23 | -21.23 | 0.00 | 32.67 | 0.00 | -- | -- | 0.00 | -46.77 | -- | -49.97 | -- | -- | -- | -- | -- | -- | -222.95 | 0.00 | -- | -- | -- | 2.26 | -- | -- | -- |
| BrightPath Biotherapeutics Co Ltd | 1.11m | -1.08bn | 9.09bn | 24.00 | -- | 5.04 | -- | 8,190.95 | -11.59 | -11.59 | 0.0117 | 13.70 | 0.0007 | -- | -- | 46,250.00 | -63.35 | -59.65 | -74.36 | -63.78 | 97.66 | 73.74 | -96,860.36 | -28,727.67 | -- | -1,103.91 | 0.00 | -- | 1,473.61 | -36.87 | 1.45 | -- | -58.41 | -- |
| Nano Holdings Inc | 141.92m | -757.17m | 10.91bn | 20.00 | -- | 3.91 | -- | 76.90 | -10.69 | -10.69 | 2.01 | 36.62 | 0.035 | 98.17 | 16.76 | 7,095,800.00 | -18.65 | -23.68 | -21.92 | -25.37 | 72.64 | 82.69 | -533.54 | -746.83 | 4.10 | -- | 0.00 | -- | -19.92 | -27.80 | -7.10 | -- | -- | -- |
| Medicinova Inc | 40.20m | -1.87bn | 12.56bn | 13.00 | -- | 1.98 | -- | 312.50 | -38.17 | -38.17 | 0.8196 | 139.71 | 0.0049 | -- | -- | 3,092,263.00 | -22.73 | -15.56 | -24.08 | -16.17 | -- | -- | -4,656.61 | -1,144.98 | -- | -- | 0.00 | -- | -100.00 | -- | -28.91 | -- | -39.68 | -- |
| Kidswell Bio Corp | 6.61bn | 281.24m | 12.90bn | 37.00 | 39.55 | 5.89 | 45.77 | 1.95 | 6.57 | 6.57 | 147.41 | 44.11 | 1.26 | 4.31 | 6.10 | 178,604,300.00 | 5.38 | -16.75 | 10.76 | -27.06 | 32.39 | 47.46 | 4.26 | -28.29 | 1.37 | -- | 0.3416 | -- | 109.03 | 36.37 | 98.51 | -- | 27.20 | -- |
